FdaApplication
ANDA 219134
Identifiers
- fda_app_no: ANDA219134
Properties
| Property | Value |
|---|---|
| applicant_name | TEVA PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 2026-06-26 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NILOTINIB HYDROCHLORIDE | NILOTINIB HYDROCHLORIDE | EQ 50MG BASE | CAPSULE;ORAL |
| NILOTINIB HYDROCHLORIDE | NILOTINIB HYDROCHLORIDE | EQ 150MG BASE | CAPSULE;ORAL |
| NILOTINIB HYDROCHLORIDE | NILOTINIB HYDROCHLORIDE | EQ 200MG BASE | CAPSULE;ORAL |
3 products